Iindaba

Siyazingca ukwazisa i-EDTA K2 yethu yodidi oluphezulu olulahlwayo kunye netyhubhu yokufunxa igazi ye-K3, eyilelwe ukuhlangabezana neyona migangatho iphezulu yoxilongo lwezonyango kunye novavanyo lwaselabhoratri. Njengomenzi othembekileyo wezinto ezityiwayo zonyango onamava angama-23 eminyaka...

Ngeemeko zesifo seswekile ezikhulayo kakhulu kwiminyaka eyi-18 edlulileyo, iingcali zonyango zaseTshayina zikhuthaza abantu ukuba baphile ngendlela enempilo. Uphononongo lwakutsha nje lufumene ukuba abantu abazizigidi ezingama-233 eTshayina babenesifo seswekile ukusukela ngo-2023, ukwanda kwepesenti ye-163 ukusuka kwi-2005.

Imibhobho ePlain (Ayikho imibhobho yokongeza), iMibhobho yeSerum (iMibhobho yeClot Activator), kunye neMibhobho ye-SST (iMibhobho yoKwahlula iSerum) ziintlobo ezintathu zetyhubhu yokuqokelela igazi esetyenziselwa ukufumana imizekelo yeserum yovavanyo lwaselabhoratri. Ngelixa babelana ngeenjongo ezifanayo...

Siyavuya ukwazisa ukugqitywa ngempumelelo kunye nokuthunyelwa kwangexesha kweodolo enkulu elungiselelwe iimfuno ezithile zomthengi wethu oxabisekileyo eMalaysia. Lo myalelo wawubandakanya iintlobo zethu ezintathu zeetyhubhu zokuqokelela igazi, ziyi-EDTA K2 PET...

Kutshanje, i-Shenzhen Institutes of Advanced Technology ye-Chinese Academy of Sciences yapapasha isiphumo sophando olusisiseko kwiNature Nanotechnology. Inkqubo ye-nanorobot yamagnetic ephuhliswe ngabo iye yafumana okokuqala unyango olupheleleyo "lokuwela umqobo wegazi-ingqondo - ukuhamba okuchanekileyo - ukuqhuma okujoliswe kuyo", ukuzisa isisombululo soguquko kwizifo zengqondo ezifana nesifo se-Alzheimer.

Washington, Juni 12, 2024 - I-US Food and Drug Administration (FDA) namhlanje ikhawulezise ukuvunywa konyango lwemfuza "SOD1-ASO" (igama lophawu lwe-Toferson) ephuhliswe yi-Swiss pharmaceutical giant Novartis kunyango lwe-amyotrophic lateral sclerosis (ALS) ebangelwa ukuguqulwa kwe-supergene dismutase (SOD1). Eli lichiza lokuqala lonyango lwemfuza elijolise kuhlobo oluthile lwe-ALS.

Uphando lwamva nje lubonisa ukuba ukungabikho kokulala kwexesha elide akukhokelela kuphela ekudinweni nasekunciphiseni imemori, kodwa kunokonyusa umngcipheko wesifo i-Alzheimer's. Iingcali zenzululwazi ziye zafumanisa ukuba ngexesha lokulala, ingqondo iqala "indlela yokucoca" ukususa iiprotheni ezinobungozi, kwaye ukuhlala kude kube sebusuku kuphazamisa le nkqubo, ukukhawuleza ukuhla kwengqondo.

I-EU ivume ukuphumelela kwe-Alzheimer's drug donanemab, eboniswa ukuhla ngokucotha kwengqondo nge-35%, kodwa ixabiso layo le-$ 30,000 yonyaka liphakamisa iinkxalabo zokufikeleleka kwizigulane kwihlabathi jikelele.

Amazwe amaninzi ase-Afrika akhuthaza isitofu sokuqala sesifo seengcongconi sehlabathi (RTS,S/AS01) ngomlinganiselo omkhulu, ejolise ekuboneleleni ngokhuseleko olubalulekileyo kubantwana ngokuchasene nesi sifo esosulelayo esibangela ukusweleka kwamakhulu amawaka minyaka le. Eli nyathelo liphawula impumelelo enkulu kwiphulo lehlabathi lokulwa nesifo seengcongconi.